ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Werble
|
130 |
45K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
45K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Werble
|
130 |
45K |
3 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
130
|
45K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix 2023 Full Year Results and Investor Webcast/Call
|
|
Werble
|
130 |
45K |
4 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
130
|
45K
|
4
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Application for quotation of securities - DXB
|
|
Werble
|
34 |
10K |
4 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
34
|
10K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Werble
|
34 |
11K |
1 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
34
|
11K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
1.5K
|
602K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
AFR - Why $3b Aussie darling Telix needs to grow wings
|
|
Werble
|
17 |
9.4K |
6 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
17
|
9.4K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
AFR - Why $3b Aussie darling Telix needs to grow wings
|
|
Werble
|
17 |
9.4K |
1 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
17
|
9.4K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Plans U.S. Registered Public Offering and Listing
|
|
Werble
|
45 |
18K |
3 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
45
|
18K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
1 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
1.5K
|
602K
|
1
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
1.4K |
688K |
5 |
20/12/23 |
20/12/23 |
ASX - By Stock
|
1.4K
|
688K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Submits BLA for TLX250-CDx for Kidney Cancer Imaging
|
|
Werble
|
44 |
14K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
44
|
14K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on Financial Reporting Requirements
|
|
Werble
|
14 |
4.3K |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
14
|
4.3K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on Financial Reporting Requirements
|
|
Werble
|
14 |
4.3K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
14
|
4.3K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Update on Financial Reporting Requirements
|
|
Werble
|
14 |
4.3K |
2 |
18/12/23 |
18/12/23 |
ASX - By Stock
|
14
|
4.3K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
6 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
1.5K
|
602K
|
6
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
5 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
1.5K
|
602K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
1.4K |
688K |
4 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
1.4K
|
688K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
1.4K |
688K |
6 |
02/12/23 |
02/12/23 |
ASX - By Stock
|
1.4K
|
688K
|
6
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
Werble
|
1.4K |
688K |
2 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
1.4K
|
688K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.4K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
17
|
5.4K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.4K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
17
|
5.4K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.4K |
9 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
17
|
5.4K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Announces Proposed Acquisition of QSAM Biosciences
|
|
Werble
|
24 |
9.0K |
6 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
24
|
9.0K
|
6
|
|
ASX - By Stock
|
TLX |
CB presenting at Jefferies London this Thursday (3am)
|
|
Werble
|
17 |
5.4K |
2 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
17
|
5.4K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
1 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
1.5K
|
602K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
53K |
5 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
138
|
53K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
53K |
0 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
138
|
53K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
53K |
11 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
138
|
53K
|
11
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
53K |
8 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
138
|
53K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
2 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
1.5K
|
602K
|
2
|
|
ASX - By Stock
|
ANR |
Re:
Ann: Anatara IBS trial positive secondary endpoint data analysis
|
|
Werble
|
6 |
2.1K |
0 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
CHM |
Re:
Ann: New data for Phase 1A CLTX CAR T brain cancer clinical trial
|
|
Werble
|
75 |
26K |
5 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
75
|
26K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
5 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
1.5K
|
602K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
53K |
5 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
53K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Q3 2023 Business Update to Accompany Quarterly Results
|
|
Werble
|
138 |
53K |
1 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
138
|
53K
|
1
|
|
ASX - By Stock
|
DXB |
Re:
DXB Chart
|
|
Werble
|
1.3K |
539K |
7 |
13/10/23 |
13/10/23 |
ASX - By Stock
|
1.3K
|
539K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Werble
|
54 |
18K |
1 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
54
|
18K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Werble
|
54 |
18K |
1 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
54
|
18K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia announces intention to voluntarily de-list from ASX
|
|
Werble
|
54 |
18K |
0 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
54
|
18K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Werble
|
645 |
234K |
4 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
645
|
234K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Werble
|
645 |
234K |
7 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
645
|
234K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Trading Halt
|
|
Werble
|
30 |
10K |
3 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
30
|
10K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: PXS Company Restructure Sale of Mannitol Business
|
|
Werble
|
12 |
4.4K |
3 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
12
|
4.4K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Werble
|
645 |
234K |
4 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
645
|
234K
|
4
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Werble
|
645 |
234K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
645
|
234K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Werble
|
645 |
234K |
2 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
645
|
234K
|
2
|
|
ASX - By Stock
|
HXL |
Re:
Ann: Board Restructure
|
|
Werble
|
7 |
2.1K |
1 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
7
|
2.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
Werble
|
1.5K |
602K |
0 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
1.5K
|
602K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 1H 2023 Results Presentation
|
|
Werble
|
102 |
30K |
7 |
26/08/23 |
26/08/23 |
ASX - By Stock
|
102
|
30K
|
7
|
|